Government Of Singapore Owned Surgical Products Company Launches ‘healthedge’ Programme To Empower Retail Chemists
The company witnessed strong performance in Q3FY25 with 37 per cent revenue growth and 322 per cent PAT growth over previous year.
Entero Healthcare Solutions Ltd, a leading healthcare product distribution platform in India, has introduced its ‘HealthEdge’ programme for retail chemists. As part of this initiative, the company has acquired the Aayu Chemist app and Medcords platform from Medcords Healthcare Solutions.
This strategic acquisition aims to accelerate the digital transformation of retail chemists by providing advanced tools to improve business efficiency, profitability, customer engagement, and purchasing experience.
With a network of over 86,000 retail chemists, Entero Healthcare seeks to strengthen its engagement within the sector. The integration of Aayu Chemist and Medcords aligns with its goal of leveraging technology to enhance healthcare distribution and drive business growth.
DSIJ offers a service 'Pop Options" with recommendations for profitable options based on research and analysis to help subscribers make healthy profits. If this interests you, then do download the service details pdf here
Commenting on this development, Mr. Prabhat Agrawal, MD & CEO of Entero Healthcare, said, “The HealthEdge programme aligns perfectly with our vision to be a growth catalyst for retail chemists. Through this digital enablement, we empower chemists to stay ahead of the curve, ensuring their businesses are resilient and primed for significant growth. Retail chemists are invited to become part of the ‘HealthEdge’ ecosystem, and together, we will shape a future where technology and healthcare distribution work hand-in-hand to unlock new levels of success.”
Shreyans, Co-Founder of Aayu Chemist by MedCords, added, "Quick commerce, with its focus on rapid delivery of everyday essentials, is impacting kirana and chemist shops in India by attracting customers seeking convenience, leading to a shift in consumer spending and potentially impacting the livelihoods of small business owners. Our journey with MedCords has always centred around empowering retail chemists, the backbone of India’s healthcare system. Partnering with Entero amplifies this mission, bringing our technology and expertise to a broader network, ensuring lakhs of chemists benefit from future-ready solutions.”
Entero Healthcare has witnessed strong performance in Q3FY25 with 37 per cent revenue growth and 322 per cent PAT growth over previous year.
Entero Healthcare Solutions Ltd (Entero) is one of India’s leading and fastest-growing healthcare products distribution platforms. Established in 2018, Entero has rapidly scaled to become a key player in the pharmaceutical supply chain with a customer base of 86,200+ retail pharmacies, 3200+ hospitals in 492 districts of India. With a network of 104 warehouses and last mile delivery infrastructure spread across the country, supply relationships with 2500+ healthcare product manufacturers Entero provides a PAN India, technology driven healthcare distribution platform. Driven by a proprietary technology platform, Entero enables seamless integration of data intelligence, demand generation, and fulfilment solutions
On Thursday, shares of Entero Healthcare Solutions Ltd jumped over 1 per cent to Rs 1,165.15 per share from its previous closing. The stock gave returns of 16 per cent in 1 year and negative 6.41 per cent since it is listed on exchange. Investors should keep an eye on this Small-Cap stock.
Disclaimer: The article is for informational purposes only and not investment advice.